Comparison of in vitro dissolution profiles of oxcarbazepine-HP β-CD tablet formulations with marketed oxcarbazepine tablets

Dissolution Technologies

Volumn 15, Issue 4, 2008, Pages 28-34

  Patel, Nirav ^a   Chotai, Narendra ^b   Patel, Jayvadan ^c   Soni, Tejal ^a   Desai, Julan ^a   Patel, Rajnikant ^d  

^a ANAND PHARMACY COLLEGE   (India)

^b AR Patel and GH Patel Institute of Pharmacy   (India)

^c NOOTAN PHARMACY COLLEGE   (India)

^d Kalol Institute of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARBOXYMETHYLCELLULOSE; MACROGOL 6000; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; OXCARBAZEPINE; POVIDONE DERIVATIVE; STARCH; TALC;

ANALYSIS OF VARIANCE; ARTICLE; DISSOLUTION; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; IN VITRO STUDY; STATISTICAL MODEL; TABLET FORMULATION; TIME SERIES ANALYSIS;

EID: 77955835300     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT150408P28     Document Type: Article

References (20)

1. Patel, N. V.; Chotai, N. P.; Patel, M. P. Tablet formulation studies on an oxcarbazepine-β cyclodextrin binary system. Die Pharmazie 2008, 63 (4), 275-281.
2. Carrico, C. K. Workshop report AAPS: USP workshop on dissolution calibration and testing. Pharm. Res. 1996, 13, 6-9.
3. Shah, V. P.; Lesko, L. J.; Fan, J.; Fleischer, N.; Handerson, J.; Malinowski, H.; Makary, M.; Ouderkirk, L.; Roy, S.; Sathe, P.; Singh, G. J. P.; Tillman, L.; Tsong, Y.; Williams, R. L. FDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Dissolution Technol. 1997, 4, 15-22.
4. Mauger, J. W.; Chilko, D.; Howard, S. On the analysis of the dissolution data. Drug Dev. Ind. Pharm. 1986, 12, 969-992.
5. Polli, J. E.; Rekhi, G. S.; Augsburger, L. L.; Shah, V. P. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci. 1997, 86, 690-700.
6. Sathe, P. M.; Tsong, Y.; Shah, V. P. In vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm. Res. 1996, 13, 1799-1803.
7. Podczeck, F. Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT). Int. J. Pharm. 1993, 97, 93-100.
8. Moore, J. W.; Flanner, H. H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996, 6, 64-74.
9. Shah, V. P.; Tsong, Y.; Sathe, P.; Liu, J.-P. In vitro dissolution profile comparison statistics and analysis of the similarity factor, f2. Pharm. Res. 1998, 15, 889-896.
10. Corrigan, O. I.; Stanley, T. Mechanism of drug dissolution rate enhancement from bcyclodextrin drug systems. J. Pharm. Pharmacol. 1982, 34, 621-626.
11. Gudrun, F. Guidelines on dissolution profile comparison. Drug Inf. J. 2001, 35, 865-874.
12. Dissolution Testing of Immediate Release Solid Oral Dosage Forms; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, 1997. http://www.fda.gov/ cder/guidance/1713bp1.pdf (accessed Sept 29, 2008).
13. Langenbucher, F. Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol. 1972, 24, 979-981.
14. Gibaldi, M.; Feldman, S. Establishment of sink conditions of dissolution rate determinations. J. Pharm. Sci. 1967, 56, 1238-1242.
15. Wagner, J. G. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J. Pharm. Sci. 1969, 58, 1253-1257.
16. Harris, M. S.; Jaweria, T.; Hamid, A.; Merchant. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak. J. Pharm. Sci. 2006, 19 (2), 119-124.
17. Coasta, P.; Sousa, L. J. M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13, 123-133.
18. United States Pharmacopeia and National Formulary USP 23-NF 18; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 1997.
19. Costa, P. An alternative method to the evaluation of similarity factor in dissolution testing. Int. J. Pharm. 2001, 220, 77-83.
20. Niebergall, P. J.; Milosovich, G.; Goyan, J. E. Dissolution rate studies II. Dissolution of particles under conditions of rapid agitation. J. Pharm. Sci. 1963, 52, 236-241